Accession PRJCA010947
Title A randomized, open-label, single-dose, two-treatment, two-period, two-way crossover bioequivalence study of febuxostat tablets in healthy subjects under fasting conditions
Relevance Medical
Data types clinical study
Organisms Homo sapiens
Description The study objectives are to compare and evaluate the bioequivalence of Febuxostat Tablets 80 mg in healthy, adult, human subjects under fasting conditions and to monitor the safety of the subjects.
Sample scope homo sapiens
Release date 2024-08-02
Grants
Agency program Grant ID Grant title
No funding support
Submitter Liping Chen (chenliping@huahaipharm.com)
Organization Zhejiang Huahai Pharmaceutical Co., Ltd
Submission date 2022-08-02

Project Data

Resource name Description